Answer
Breastfeeding should be avoided during Tavlesse (fostamatinib) treatment and for at least one month after the last dose.
Sources for this answer
- Tavlesse 100 mg film-coated tabletsGrifols UK Ltd · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 3Document updated
Sources checked